Evidence-Based Medicine Guidelines
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Calcimimetics for Secondary Hyperparathyroidism in Chronic Kidney Disease Patients." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456360/all/_________Calcimimetics_for_secondary_hyperparathyroidism_in_chronic_kidney_disease_patients______.
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/456360/all/_________Calcimimetics_for_secondary_hyperparathyroidism_in_chronic_kidney_disease_patients______. Accessed April 21, 2025.
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/456360/all/_________Calcimimetics_for_secondary_hyperparathyroidism_in_chronic_kidney_disease_patients______
Calcimimetics for Secondary Hyperparathyroidism in Chronic Kidney Disease Patients [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456360/all/_________Calcimimetics_for_secondary_hyperparathyroidism_in_chronic_kidney_disease_patients______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients
ID - 456360
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456360/all/_________Calcimimetics_for_secondary_hyperparathyroidism_in_chronic_kidney_disease_patients______
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
